Scisparc Ltd
SPRC5.819USD
+0.119+2.09%
Trading geöffnet （ET）Kurse um 15 Minuten verzögert
290.71KMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Scisparc Ltd Unternehmen
Scisparc Ltd, former Therapix Biosciences Ltd is a Israel-based pharmaceutical company commited into creating and enhancing technologies and assets based on cannabinoid pharmaceuticals. The company is engaged in drug development programs based on repurposing a cannabinoid (Dronabinol): THX-110 for the treatment of Tourette syndrome (TS), for the treatment of Obstructive Sleep Apnea (OSA), and the treatment of Pain; THX-130 for the treatment of Mild Cognitive Impairment (MCI) and Traumatic Brain Injury (TBI); THX-150 for the treatment of infectious diseases; and THX-160 for the treatment of pain.
Unternehmensinformationen
BörsenkürzelSPRC
Name des UnternehmensScisparc Ltd
IPO-datumDec 22, 2021
CEOMr. Amitay Weiss
Anzahl der mitarbeiter2
WertpapierartOrdinary Share
GeschäftsjahresendeDec 22
Addresse20 Raul Wallenberg Street, Tower A
StadtTEL AVIV-YAFO
BörseNASDAQ Capital Market Consolidated
LandIsrael
Postleitzahl6971916
Telefon97236103100
Websitehttps://scisparc.com/
BörsenkürzelSPRC
IPO-datumDec 22, 2021
CEOMr. Amitay Weiss
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Itschak Shrem
Mr. Itschak Shrem
Chairman of the Board
Chairman of the Board
16.00
+128.57%
Mr. Amitay Weiss
Mr. Amitay Weiss
Chief Executive Officer, Director
Chief Executive Officer, Director
1.00
--
Prof. Ari Shamiss, M.D.
Prof. Ari Shamiss, M.D.
Independent Director
Independent Director
--
--
Mr. Alon Dayan
Mr. Alon Dayan
Independent Director
Independent Director
--
--
Dr. Adi Zuloff-Shani
Dr. Adi Zuloff-Shani
Chief Technology Officer
Chief Technology Officer
--
--
Mr. Amnon Shay
Mr. Amnon Shay
Independent Director
Independent Director
--
--
Mr. Moshe Revach
Mr. Moshe Revach
Director
Director
--
--
Mr. Lior Vider
Mr. Lior Vider
Independent Director
Independent Director
--
--
Ms. Liat Sidi
Ms. Liat Sidi
Director
Director
--
--
Mr. Oz Adler, CPA
Mr. Oz Adler, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Itschak Shrem
Mr. Itschak Shrem
Chairman of the Board
Chairman of the Board
16.00
+128.57%
Mr. Amitay Weiss
Mr. Amitay Weiss
Chief Executive Officer, Director
Chief Executive Officer, Director
1.00
--
Prof. Ari Shamiss, M.D.
Prof. Ari Shamiss, M.D.
Independent Director
Independent Director
--
--
Mr. Alon Dayan
Mr. Alon Dayan
Independent Director
Independent Director
--
--
Dr. Adi Zuloff-Shani
Dr. Adi Zuloff-Shani
Chief Technology Officer
Chief Technology Officer
--
--
Mr. Amnon Shay
Mr. Amnon Shay
Independent Director
Independent Director
--
--
Umsatzaufteilung
Keine Daten
Keine Daten
Nach Geschäftsbereich
Nach Region
Keine Daten
Aktionärsstatistik
Aktualisiert: Wed, May 21
Aktualisiert: Wed, May 21
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Two Sigma Investments, LP
0.60%
Yorkville Advisors Global, LP.
0.49%
Other
98.91%
Aktionäre
Aktionäre
Anteil
Two Sigma Investments, LP
0.60%
Yorkville Advisors Global, LP.
0.49%
Other
98.91%
Aktionärstypen
Aktionäre
Anteil
Hedge Fund
0.60%
Investment Advisor/Hedge Fund
0.49%
Other
98.91%
Institutionelle Beteiligung
Aktualisiert: Tue, Jul 1
Aktualisiert: Tue, Jul 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q2
20
5.88K
1.10%
-4.32K
2025Q1
22
123.94K
1.13%
-90.52K
2024Q4
22
186.52K
1.22%
-6.68K
2024Q3
20
179.36K
1.73%
+90.02K
2024Q2
22
138.03K
12.19%
+104.31K
2024Q1
20
67.89K
2.29%
+37.60K
2023Q4
19
11.96K
4.65%
-10.95K
2023Q3
23
5.71K
4.48%
-17.08K
2023Q2
22
12.21K
6.80%
-11.05K
2023Q1
20
14.22K
7.92%
-4.38K
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Two Sigma Investments, LP
3.21K
0.6%
+1.30K
+68.47%
Mar 31, 2025
Yorkville Advisors Global, LP.
2.63K
0.49%
+2.63K
--
Feb 27, 2024
Shrem (Itschak)
16.00
0%
+9.00
+128.57%
Apr 23, 2025
SBI Securities Co., Ltd.
14.00
0%
+11.00
+366.67%
Mar 31, 2025
BofA Global Research (US)
2.00
0%
-4.00
-66.67%
Mar 31, 2025
Rhumbline Advisers Ltd. Partnership
1.00
0%
-164.00
-99.39%
Mar 31, 2025
Weiss (Amitay)
1.00
0%
--
--
Apr 23, 2025
J.P. Morgan Securities LLC
--
0%
-22.00
-100.00%
Mar 31, 2025
Morgan Stanley & Co. LLC
--
0%
-18.00
-100.00%
Mar 31, 2025
Virtu Americas LLC
--
0%
-672.00
-100.00%
Dec 31, 2024
Mehr Anzeigen
Verbundene ETFs
Name
Anteil
Keine Daten
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Sep 20, 2023
Merger
26<1
Sep 20, 2023
Merger
26<1
Sep 20, 2023
Merger
26<1
Sep 20, 2023
Merger
26<1
Datum
Art
Verhältnis
Sep 20, 2023
Merger
26<1
Sep 20, 2023
Merger
26<1
Sep 20, 2023
Merger
26<1
Sep 20, 2023
Merger
26<1
